ARCA biopharma, Inc.
ABIO
|
$3.21
-1.23%
7.4K
|
Health Technology
(0.0% 1d) (83.4% 1m) (62.3% 1y) (0.0% 2d) (0.0% 3d) (0.9% 7d) (-67.77% volume)
Earnings Calendar:
Market Cap: $ 46,548,669
http://www.arcabiopharma.com
Sec Filling | Patents | 13 employees
(US) ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company engages in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, Gencaro is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.
cardiovascular heart genetic treatment
add to watch list Paper trade email alert is off
Press-releases
INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ChampionX Corp. - CHX
Published: 2024-04-10 (Crawled : 01:00) - prnewswire.com
ABIO | $3.21 -1.23% 7.4K
|
Health Technology
|
| O: 1.62%
H: 1.92%
C: 0.32%
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Kintara Biopharma, Inc. - KTRA
Published: 2024-04-10 (Crawled : 01:00) - prnewswire.com
SWAV | $327.81 0.09% 270K
|
Health Technology
|
| O: -0.32%
H: 1.09%
C: 1.02%
KTRA | $0.1181 10.79% 3.3M
|
Distribution Services
|
| O: -2.17%
H: 0.15%
C: -1.69%
ABIO | $3.21 -1.23% 7.4K
|
Health Technology
|
| O: 1.62%
H: 1.92%
C: 0.32%
Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm
Published: 2024-04-05 (Crawled : 18:00) - prnewswire.com
SUN 2 d | $54.93 1.03% 10K
|
Distribution Services
|
| O: 0.0%
H: 0.14%
C: -1.49%
NS 2 d | $22.03 1.76% 28K
|
Distribution Services
|
| O: -0.44%
H: 0.96%
C: -0.09%
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: -1.84%
H: 0.0%
C: 0.0%
SWAV | $327.81 0.09% 270K
|
Health Technology
|
| O: 1.21%
H: 0.65%
C: 0.25%
KTRA | $0.1181 10.79% 3.3M
|
Distribution Services
|
| O: -13.08%
H: 8.09%
C: 4.16%
ABIO | $3.21 -1.23% 7.4K
|
Health Technology
|
| O: -3.9%
H: 7.09%
C: 4.39%
ARCA biopharma Announces 2023 Financial Results
Published: 2024-02-01 (Crawled : 22:00) - globenewswire.com
ABIO | $3.21 -1.23% 7.4K
|
Health Technology
|
| O: -0.32%
H: 5.1%
C: 3.18%
biopharma financial results
ARCA biopharma Announces Third Quarter 2023 Financial Results
Published: 2023-10-18 (Crawled : 20:00) - globenewswire.com
ABIO | $3.21 -1.23% 7.4K
|
Health Technology
|
| O: -0.88%
H: 0.89%
C: 0.39%
biopharma financial results
Global Aptamers Market Landscape 2023-2030: Diagnostics Segment Set for Rapid Expansion, North America Holds Key Position
Published: 2023-08-22 (Crawled : 18:00) - prnewswire.com
ABIO | $3.21 -1.23% 7.4K
|
Health Technology
|
| O: -0.49%
H: 1.47%
C: 0.98%
america rapid global set diagnostics market
ARCA biopharma Announces Second Quarter 2023 Financial Results
Published: 2023-07-21 (Crawled : 20:00) - globenewswire.com
ABIO | $3.21 -1.23% 7.4K
|
Health Technology
| Email alert
Add to watchlist
biopharma financial results
ARCA biopharma Announces First Quarter 2023 Financial Results
Published: 2023-04-24 (Crawled : 21:00) - globenewswire.com
ABIO | $3.21 -1.23% 7.4K
|
Health Technology
|
| O: 0.0%
H: 1.21%
C: 0.0%
biopharma financial results
ARCA biopharma Announces Third Quarter 2022 Financial Results
Published: 2022-10-28 (Crawled : 21:00) - globenewswire.com
ABIO | $3.21 -1.23% 7.4K
|
Health Technology
| Email alert
Add to watchlist
biopharma financial results
ARCA biopharma Reports Topline Results for ASPEN-COVID-19 Phase 2b Clinical Trial
Published: 2022-03-31 (Crawled : 23:00) - biospace.com/
ABIO | $3.21 -1.23% 7.4K
|
Health Technology
|
| O: -1.72%
H: 7.89%
C: 0.88%
covid-19 biopharma topline trial results phase 2b
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 81% | 19% |
Top 10 Gainers
AGBA | News | $1.37 242.5% 76M
|
Finance
EGOX | $0.0835 131.94% 160M
|
ZCMD | $2.18 50.35% 24M
|
Commercial Services
CHRO | $1.73 41.22% 46K
|
n/a
RWOD | $10.61 32.68% 5.1M
|
n/a
NVFY | $2.77 31.28% 2.2M
|
Consumer Durables
AULT | $0.3174 31.1% 28M
|
Manufacturing
WISA 4 | $7.11 20.71% 4.7M
|
Electronic Technology
LIFW | News | $0.99 19.26% 800K
|
Administrative and Support and ...
PRTG | $0.285 18.75% 140K
|
Mining, Quarrying, and Oil and ...
Last 48 Hours Insiders Buying
CLSD | $1.35 2.27% 35K
|
Health Technology
|
14:00
CDZI P 25000 | $2.32 3.11% 35K
|
Utilities
|
14:00
ETST P 39000 | $0.068 4.61% 0
|
Manufacturing
|
13:30
FNLC P 1275 | $22.55 1.76% 4.2K
|
Finance
|
12:30
ADMQ | $0.0532 -4.14% 0
|
|
10:30
AXR P 2400 | $22.26 0.41% 110
|
Finance
|
21:00
QCRH P 118 | $56.39 1.77% 8.1K
|
Finance
|
18:01
VUZI P 7500 | $1.225 -2.78% 100K
|
Electronic Technology
|
18:00
RMCF | $3.5501 310
|
Consumer Non-Durables
|
20:10